Back

Cardiomyocyte-Restricted High-mobility group box 1 (HMGB1) Deletion Leads to small heart and inflammation Through GR/PGC-1a signaling

28 August 2020 (08:00 - 18:00)
Organised by:
Congress Presentation Part of: Basic Science Cardiac ePosters Metabolism ESC Premium Access ESC Congress 2020

About the speaker

Photo
Doctor Peng Yu

Zhongshan Hospital, Shanghai (China)

110 More presentations in this session

Presentation thumbnail
Elimination of senescent cells targeting Senescence associated glycoprotein (SAGP) improved the ageing-associated diseases and extended the lifespan
Doctor M. Suda (Tokyo, JP)
Abstract Slides
Presentation thumbnail
Single-cell RNA sequencing of human fetal epicardium reveals novel markers and regulators of EMT
Mr T. Streef (Leiden, NL)
Abstract Slides
Presentation thumbnail
Genome-wide association study identifies 18 new susceptibility variants loci associated with Brugada Syndrome
Associate Professor J. Barc (Nantes, FR)
Abstract Slides
Presentation thumbnail
Mutations in CHMP4C cause dilated cardiomyopathy via dysregulation of autophagy
Doctor N. Zhou (Shanghai, CN)
Abstract Slides
Presentation thumbnail
Disruption of the architecture of the junctional sarcoplasmic reticulum in recessive catecholaminergic polymorphic ventricular tachycardia is caused by the er-shaping proteins reep5 and climp63
Doctor R. Bongianino (Pavia, IT)
Abstract Slides

Access the full session

Session thumbnail
Basic Science Cardiac ePosters

The Event

Event poster

ESC Congress 2020

28 August 2020 08:00 CET
You may be interested in
thumbnail
Congress Presentation
High mobility group box 1 predicts mortality and systemic organ dysfunction in cardiology intensive care patients
20 March 2026
thumbnail
Congress Presentation
Skeletal muscle-selective deletion of iron regulatory protein 1 and 2 in mice impairs exercise tolerance and cardiac adaptation to increased afterload.
20 May 2023
thumbnail
Congress Presentation
Genetic regulation of myocardial fibrosis in hypertrophic cardiomyopathy
27 August 2021
thumbnail
Congress Presentation
Targeted cardiac inactivation of Guanylate binding protein 5 (GBP5) protects from cardiotoxicity after doxorubicin treatment
20 June 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources